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Introduction
The classification of Drosophila hemocytes initially relied 
on morphological distinction between hemocyte types. To 
facilitate the identification of the different effector cell classes, 
an array of molecular markers was created. One of these mark-
ers is NimrodC1 (NimC1), which was identified on the surface 
of the Drosophila phagocytes (plasmatocytes) by the mixture of 
2 monoclonal antibodies (P1a and P1b).1 Functional assess-
ment of NimC1 in plasmatocytes and S2 cells proved that 
it plays a role in the phagocytosis of bacteria.1 These results 
were further underlined by in vitro analysis, which showed the 
direct binding of NimC1 to f luorescently labeled bacteria.2 
Structural investigation of the protein revealed that it con-
tains a set of characteristic EGF-like domains (NIM domains), 
which can also be found in a set of proteins potentially 
related to phagocytosis; these proteins constitute the Nimrod 
protein-family.3
In the past years, NimC1 has become the standard 
marker for the identification of Drosophila plasmatocytes.4-9 
However, it was recently observed that there is a variation in 
the expression of the NimC1 receptor among Drosophila lines. 
As NimC1 is broadly used as a marker for plasmatocytes, we 
performed an analysis involving the nimC1 gene to find an 
explanation for this phenomenon.
Results and Discussion
To find out the reason for the lack of the NimC1 antigen in 
some stocks and genetic combinations (Fig. 1A), we analyzed the 
expression of the nimC1 gene in NimC1 negative and NimC1 
positive strains using RT-PCR. According to the data available 
on FlyBase (http://flybase.org/), 2 transcripts, nimC1-RA and 
nimC1-RB are annotated; therefore, we used isoform specific 
primer pair sets to identify the predicted transcripts. We detected 
both transcripts in all of the investigated lines, however, in P1 
negative lines (w1118 [BL#6326], w1118; Cg-Gal4 [BL#7011] and 
w1118; Hml-Gal4.Δ, UAS-2XEGFP [BL#30140]) the transcripts 
were 350 bp shorter than in the P1 positive ones (Oregon-R) and 
w1118 (BL#5905) (Fig. 1B). Hemese10 specific primers gave the 
appropriate sized products in each sample.
To reveal the grounds for the difference in size of nimC1 tran-
scripts, we performed a genome-sequence analysis. We found 2 
independent deletions in the nimC1 gene of the P1 negative lines. 
One of them is a 6 bp microdeletion from nucleotides 2264 to 2270 
(2L:13974483-2L:13974489), while the other one covers 355 
bps from nucleotides 1582 to 1937 (2L:13974817-2L:13975172), 
accompanied by a 5 bp long insertion (at position 2L:13974817) 
(Fig. 1C). The latter deletion and the insertion are presumable 
results of the excision of a mobile element, which are known to 
leave footprints in the genome after remobilization.
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The 355 bp deletion and the 5 bp insertion generate a frame-
shift mutation in both nimC1 transcripts. As a result of the 
frameshift, the insertion is followed by a newly arisen sequence 
of 12 codons and a UGA stop codon (Fig. 1C). These altera-
tions suggest that the mutant NimC1 proteins may be trun-
cated. Instead of the normal 620 and 622 amino acid residues, 
the mutant NimC1 proteins are composed of only 307 and 309 
amino acids in the case of the NimC1-PA and the NimC1-PB, 
respectively. The truncated NimC1 proteins, therefore, lack their 
C-terminal regions, including their intracellular and transmem-
brane domains, as well as four NIM repeats from the extracellu-
lar region (Fig. 1C). As the deletions do not affect the N-terminal 
signal peptide, the truncated proteins of the mutant lines may be 
secreted to the hemolymph, and in this particular case, resemble 
the NimB proteins, the secreted members of the Nimrod pro-
tein family.1,3 As the NimC1 antigen was not detected in the 
Figure 1. expression and sequence analysis of NimC1 (A) NimC1 (P1a/P1b) staining of larval hemocytes (red) in different Drosophila lines. In the case 
of transgenic lines, GrP expression was amplified with anti-GFP (green) (B) agarose gel electrophoresis of rT-PCr products gained with primer pairs 
specific for nimC1-ra (1138 bp or 788 bp), nimC1-rB (1268 bp or 918 bp), and Hemese (175 bp) transcripts. In case of w1118; Hml-Gal4.Δ, UAS-2XEGFP strain, 
genomic DNa contamination was observed; we detected a 1016 bp band besides the cDNa specific 910 bp fragment. (C) Map of the nimC1 open read-
ing frame, the transcripts and the predicted truncated NimC1 proteins of the P1 negative strains, compared with the wild-type NimC1. Since the size of 
nimC1-RA and nimC1-RB transcripts differ in only 6 bp, the difference between the isoforms is not indicated. The deleted segments are indicated by their 
respective start and end positions, connected by a horizontal line.
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hemolymph in the tested mutant lines (data not shown), the spe-
cific epitopes for the P1a and P1b monoclonal antibodies may be 
located on the missing protein regions.
In order to assess whether P1 positivity can be regained by 
recombination, we replaced the mutant nimC1 gene with the 
wild-type allele of a P1 positive line. We successfully restored the 
P1 positivity of the w1118; Hml-GAL4.Δ, UAS-2xEGFP12 line by 
exchanging the chromosomal region in which NimC1 is located 
(34E5) using black (34D1) as a marker gene for recombination 
(the resulting R3-w1118; Hml-Gal4.Δ, nimC1+, UAS-2XEGFP stock 
is available for the scientific community upon request, from VH).
Our results imply that some of the P1 negative lines used in 
the laboratories are nimC1 mutants, while the majority of the lab-
oratory stocks express NimC1. It should be noted, therefore, that 
multistep genetic crosses, such as lineage tracing combinations, 
may results in the introduction of nimC1 mutant chromosomes. 
For this reason, a rigorous test for NimC1 expression is necessary.
Investigation of hemocyte differentiation requires the detection 
of NimC1 expression. Basic genetic analysis demonstrated that the 
occurrence of the P1-negative phenotype is consistent with the 
presence of a recessive mutation on the second chromosome. Thus, 
when it is suspected that P1 negativity is the result of the genetic 
background (as in the case of progeny emerging from GAL4/UAS 
crosses), it is advisable to check the parental chromosomes for P1 
staining. This can be done by test crossing the parental lines to 
known P1-negative and P1-positive lines, and checking for P1 
expression in the trans-heterozygous F1 progeny. Therefore, we 
recommend using the nimC1 mutants in heterozygous conditions, 
and if unavoidable, the nimC1 mutant locus can be recombined 
with the black marker gene to gain a P1 positive line. For a list of 
confirmed P1 negative stocks, please refer to Table S2.
P1-negative chromosomes harboring FRT elements for mitotic 
clone generation represent a special case. Mitotic clones are gener-
ated to examine the phenotypic effects of homozygous mutation 
of a given gene. If the P1-negative locus resides on the same arm, 
then the resulting FRT clones in blood cells (in the lymph gland or 
circulating hemocytes) will also be P1-negative, while surrounding 
heterozygous cells, often used as an internal experimental control, 
will be P1-positive. Without knowing the P1 status of the chromo-
some beforehand, the P1-negative phenotype may be erroneously 
attributed to the mutant locus under study. The test crossing men-
tioned above helps to avoid such interpretational errors.
Functional tests, such as phagocytosis assay, can also be used 
to monitor plasmatocyte differentiation in P1 negative genetic 
lines and crosses11; however, NimC1 is still the simplest and one 
of the most appropriate tools to detect the phagocytic cells in the 
majority of the possible genetic backgrounds.
Materials and Methods
Drosophila stocks and genetic crosses
Wild-type Oregon-R, 2 w1118 strains (NimC1 positive BL#5905 
and NimC1 negative BL#6326), w1118; Cg-Gal4 (BL#7011), w1118; 
Hml-Gal4.Δ, UAS-2XEGFP (BL#30140) and a meiotic mapping 
line containing the b1 mutation, (a gift from Dr László Sipos, 
BRC, Szeged, Hungary) were used. The P1 positive R3-w1118; 
Hml-Gal4.Δ, UAS-2XEGFP line was generated in 2 recombina-
tion steps. First, the region containing the b1 marker (located in 
the 34D1 region) was recombined into the Hml-Gal4.Δ, UAS-
2XEGFP chromosome, then it was exchanged with the respective 
genomic region of a wild-type (b+) chromosome. The flies were 
kept on a standard cornmeal-yeast diet at 25°C.
Isolation of RNA and cDNA synthesis
The RNA was isolated from third instar larvae using TRIzol 
Reagent (Invitrogen). The contaminating DNA was eliminated 
by DNase I treatment (Fermentas): 1 µg RNA was treated with 
1 u DNase I and then reverse transcribed using RevertAid First 
Strand cDNA Synthesis Kit (Fermentas).
Analysis of nimC1 expression
The primers used for the analysis are described in Table S1. 
To detect the transcription of nimC1, we performed reverse tran-
scription polymerase chain reactions (RT-PCR) with isoform-
specific primers using 1 µl undiluted cDNA as template. The 
P1A2 forward and the P1del.utanA,B reverse primers were used 
to amplify a 1138 bp fragment of the nimC1-RA transcript. 
Samples eventually contaminated with genomic DNA would 
result in the synthesis of a 1735 bp PCR fragment. As the nimC1 
specific forward primer is inappropriate to amplify the nimC1-
RB transcript the P1isoBfw forward primer was used in combi-
nation with the P1del.utanA,B reverse primer. This primer pair 
amplifies a 1268 bp fragment in case if cDNA and a 1365 bp 
fragment if genomic DNA is used as template. As a positive con-
trol, the Hemese10 specific Hemesefw forward and Hemeserev 
reverse primers were used, which generated a 175 bp fragment. 
In case of genomic DNA contamination, a 354 bp PCR fragment 
was expected.
Immunostaining and hemocyte imaging
Larvae were dissected in 20 µl of Shields and Sang’s medium 
(Sigma) on a multispot microscope slide (SM-011, Hendley); the 
released hemocytes were allowed to settle and adhere at room 
temperature for 45 min. The samples were fixed with parafor-
maldehyde (2% paraformaldehyde in PBS, 12 min), washed and 
blocked for 15 min with PBS containing 0.1% BSA (Sigma), 
incubated with the respective monoclonal antibodies for 1 h at 
room temperature, washed three times with PBS and reacted 
with anti-mouse Alexa Fluor 568 (Sigma) immunoglobulin at 
1:1000 dilution for 1 h. The GFP signal was enhanced with rab-
bit anti-GFP antibody (Sigma, 1:2000 dilution) in combination 
with Alexa Fluor 488-conjugated anti-rabbit immunoglobu-
lin (Sigma, 1:1000 dilution). Nuclei were stained with DAPI 
(Sigma). The microscopic analysis was performed with a Zeiss 
Axioskope 2MOT epifluorescent microscope.
Genome sequence analysis
Genomic DNA was isolated from female adult flies using the 
GenEluteTM Mammalian Genomic DNA Miniprep Kit (Sigma). 
For each reaction, 100 ng DNA was used as template. To amplify 
a 752 bp long fragment including the 5′ end of the gene and 
a short intergenic region, we used the P11exonF and P11exonR 
primers. Proceeding toward the 3′ end of the nimC1 gene the 
following primer sets were used: P1isoBfw-P1B600rev (which 
amplify a 579 bp fragment), P11189fw-P11189rev (which amplify 
a 1254 bp fragment), and P1utan600fw-P1utan300rev to amplify 
266 Fly Volume 7 Issue 4
 References
1. Kurucz E, Márkus R, Zsámboki J, Folkl-
Medzihradszky K, Darula Z, Vilmos P, et al. Nimrod, 
a putative phagocytosis receptor with EGF repeats in 
Drosophila plasmatocytes. Curr Biol 2007; 17:649-
54; PMID:17363253; http://dx.doi.org/10.1016/j.
cub.2007.02.041
2. Zsámboki J, Csordás G, Honti V, Pintér L, Bajusz I, 
Galgóczy L, et al. Drosophila Nimrod proteins bind 
bacteria. Cent. Eur. J. Biol. 2013; 7:633-45; http://
dx.doi.org/10.2478/s11535-013-0183-4
3. Somogyi K, Sipos B, Pénzes Z, Kurucz E, Zsámboki 
J, Hultmark D, et al. Evolution of genes and repeats 
in the Nimrod superfamily. Mol Biol Evol 2008; 
25:2337-47; PMID:18703524; http://dx.doi.
org/10.1093/molbev/msn180
4. Mandal L, Martinez-Agosto JA, Evans CJ, 
Hartenstein V, Banerjee UA. A Hedgehog- and 
Antennapedia-dependent niche maintains Drosophila 
haematopoietic precursors. Nature 2007; 446:320-
4; PMID:17361183; http://dx.doi.org/10.1038/
nature05585
5. Sinenko SA, Hung T, Moroz T, Tran QM, Sidhu S, 
Cheney MD, et al. Genetic manipulation of AML1-
ETO-induced expansion of hematopoietic precursors 
in a Drosophila model. Blood 2010; 116:4612-20; 
PMID:20688956; http://dx.doi.org/10.1182/
blood-2010-03-276998
6. Makki R, Meister M, Pennetier D, Ubeda JM, Braun 
A, Daburon V, et al. A short receptor downregulates 
JAK/STAT signalling to control the Drosophila cel-
lular immune response. PLoS Biol 2010; 8:e1000441; 
PMID:20689801; http://dx.doi.org/10.1371/jour-
nal.pbio.1000441
7. Cordero JB, Macagno JP, Stefanatos RK, Strathdee 
KE, Cagan RL, Vidal M. Oncogenic Ras diverts a host 
TNF tumor suppressor activity into tumor promoter. 
Dev Cell 2010; 18:999-1011; PMID:20627081; 
http://dx.doi.org/10.1016/j.devcel.2010.05.014
8. Tokusumi T, Tokusumi Y, Hopkins DW, Shoue 
DA, Corona L, Schulz RA. Germ line differentia-
tion factor Bag of Marbles is a regulator of hemato-
poietic progenitor maintenance during Drosophila 
hematopoiesis. Development 2011; 138:3879-84; 
PMID:21813570; http://dx.doi.org/10.1242/
dev.069336
9. Márkus R, Laurinyecz B, Kurucz É, Honti V, Bajusz 
I, Sipos B, et al. Sessile hemocytes as a hematopoietic 
compartment in Drosophila melanogaster. Proc Natl 
Acad Sci U S A 2009; 106:4805-9; PMID:19261847; 
http://dx.doi.org/10.1073/pnas.0801766106
10. Kurucz E, Zettervall CJ, Sinka R, Vilmos P, Pivarcsi 
A, Ekengren S, et al. Hemese, a hemocyte-specific 
transmembrane protein, affects the cellular immune 
response in Drosophila. Proc Natl Acad Sci U S A 
2003; 100:2622-7; PMID:12598653; http://dx.doi.
org/10.1073/pnas.0436940100
11. Honti V, Csordás G, Márkus R, Kurucz E, Jankovics 
F, Andó I. Cell lineage tracing reveals the plasticity of 
the hemocyte lineages and of the hematopoietic com-
partments in Drosophila melanogaster. Mol Immunol 
2010; 47:1997-2004; PMID:20483458; http://
dx.doi.org/10.1016/j.molimm.2010.04.017
12. Sinenko SA, Mathey-Prevot B. Increased expres-
sion of Drosophila tetraspanin, Tsp68C, suppresses 
the abnormal proliferation of ytr-deficient and Ras/
Raf-activated hemocytes. Oncogene 2004; 23:9120-
8; PMID:15480416; http://dx.doi.org/10.1038/
sj.onc.1208156 
the 3′ end of the gene and a short intergenic region (yielding a 
593 bp fragment). The sequences of the primers are indicated in 
Table S1. Sequence analysis of the obtained PCR fragments was 
performed using BigDye Terminator v3.1 Cycle Sequencing Kit 
(Invitrogen) and a 3500-Genetic Analyzer (Applied Biosystems).
Disclosure of Potential Conflicts of Interest
No potential conflicts of interest were disclosed.
Acknowledgments
We are grateful to Olga Kovalcsik, Szilvia Tápai, and Anita 
Balázs for technical help. We acknowledge the constructive 
criticism of the two unnamed referees. This research was sup-
ported by grants from the Hungarian Science Foundation (OTKA 
grant NK 101730), TÁMOP 4.2.2.A-11/1KONV-2012-0035 
(IA), a National Institutes of Health grant R01HL67395 (UB), 
and GCs had a Junior Scientist Fellowship from the Hungarian 
Academy of Sciences.
Supplemental Materials
Supplemental materials may be found here: 
http://www.landesbioscience.com/journals/fly/article/25654
